Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Crescent BDC upgraded to Outperform from Perform at Oppenheimer » 09:30
08/12/22
08/12
09:30
08/12/22
09:30
CCAP

Crescent BDC

$17.24 /

+0.04 (+0.23%)

Oppenheimer analyst…

Oppenheimer analyst Mitchel Penn upgraded Crescent BDC to Outperform from Perform with a price target of $19, down from $20.

ShowHide Related Items >><<
CCAP Crescent BDC
$17.24 /

+0.04 (+0.23%)

03/07/22 Wells Fargo
Crescent BDC initiated with an Overweight at Wells Fargo
01/31/22 BofA
Crescent BDC initiated with a Buy at BofA
01/31/22 BofA
Crescent BDC initiated with a Buy at BofA
CCAP Crescent BDC
$17.24 /

+0.04 (+0.23%)

  • 16
    Nov
CCAP Crescent BDC
$17.24 /

+0.04 (+0.23%)

Over a quarter ago
Earnings
Crescent BDC reports Q1 adjusted NII 42c, consensus 41c » 17:00
05/09/22
05/09
17:00
05/09/22
17:00
CCAP

Crescent BDC

$17.40 /

-0.29 (-1.64%)

Reported net asset value…

Reported net asset value per share was $21.18 as of March 31, 2022 as compared to $21.12 as of December 31, 2021.

ShowHide Related Items >><<
CCAP Crescent BDC
$17.40 /

-0.29 (-1.64%)

03/07/22 Wells Fargo
Crescent BDC initiated with an Overweight at Wells Fargo
01/31/22 BofA
Crescent BDC initiated with a Buy at BofA
01/31/22 BofA
Crescent BDC initiated with a Buy at BofA
07/16/21 Oppenheimer
Crescent BDC initiated with a Perform, $19 target at Oppenheimer
  • 16
    Nov
CCAP Crescent BDC
$17.40 /

-0.29 (-1.64%)

CCAP Crescent BDC
$17.40 /

-0.29 (-1.64%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:04
03/07/22
03/07
10:04
03/07/22
10:04
FIVE

Five Below

$154.00 /

+4.5 (+3.01%)

, CRI

Carter's

$95.22 /

+1.01 (+1.07%)

, PLTR

Palantir

$11.52 /

+0.57 (+5.21%)

, NTLA

Intellia Therapeutics

$63.52 /

-1.585 (-2.43%)

, NTR

Nutrien

$98.79 /

+3.75 (+3.95%)

, DKNG

DraftKings

$19.50 /

-1.19 (-5.75%)

, MGM

MGM Resorts

$40.21 /

-1.31 (-3.16%)

, WYNN

Wynn Resorts

$77.66 /

-3.62 (-4.45%)

, AAL

American Airlines

$14.07 /

-0.53 (-3.63%)

, RL

Ralph Lauren

$111.24 /

-4.68 (-4.04%)

, PVH

PVH Corp.

$75.11 /

-4.11 (-5.19%)

, PM

Philip Morris

$95.22 /

-4.52 (-4.53%)

, SOFI

SoFi Technologies

$9.98 /

-0.02 (-0.20%)

, NVDA

Nvidia

$223.94 /

-5.27 (-2.30%)

, PRTG

Portage Biotech

$7.59 /

-0.02 (-0.26%)

, SGHC

Super Group

$7.99 /

-0.16 (-1.96%)

, CCAP

Crescent BDC

$17.55 /

+0.025 (+0.14%)

Institutional investors…

ShowHide Related Items >><<
WYNN Wynn Resorts
$77.66 /

-3.62 (-4.45%)

SOFI SoFi Technologies
$9.98 /

-0.02 (-0.20%)

SGHC Super Group
$7.99 /

-0.16 (-1.96%)

RL Ralph Lauren
$111.24 /

-4.68 (-4.04%)

PVH PVH Corp.
$75.11 /

-4.11 (-5.19%)

PRTG Portage Biotech
$7.59 /

-0.02 (-0.26%)

PM Philip Morris
$95.22 /

-4.52 (-4.53%)

PLTR Palantir
$11.52 /

+0.57 (+5.21%)

NVDA Nvidia
$223.94 /

-5.27 (-2.30%)

NTR Nutrien
$98.79 /

+3.75 (+3.95%)

NTLA Intellia Therapeutics
$63.52 /

-1.585 (-2.43%)

MGM MGM Resorts
$40.21 /

-1.31 (-3.16%)

FIVE Five Below
$154.00 /

+4.5 (+3.01%)

DKNG DraftKings
$19.50 /

-1.19 (-5.75%)

CRI Carter's
$95.22 /

+1.01 (+1.07%)

AAL American Airlines
$14.07 /

-0.53 (-3.63%)

FIVE Five Below
$154.00 /

+4.5 (+3.01%)

03/07/22 UBS
Five Below upgraded to Buy from Neutral at UBS
01/14/22 KeyBanc
Five Below upgraded to Overweight from Sector Weight at KeyBanc
01/14/22 KeyBanc
Five Below upgraded to Overweight from Sector Weight at KeyBanc
01/12/22 Truist
Truist starts Five Below at Buy, highlights 'strong' economic model
CRI Carter's
$95.22 /

+1.01 (+1.07%)

03/07/22 Wedbush
Carter's upgraded to Outperform from Neutral at Wedbush
02/28/22 Citi
Carter's price target raised to $127 from $124 at Citi
01/31/22 CL King
Carter's strong operating model to dominate FY22, says CL King
10/04/21 Wedbush
Wedbush sees several key tailwinds for footwear and apparel sector
PLTR Palantir
$11.52 /

+0.57 (+5.21%)

03/07/22 Morgan Stanley
Palantir upgraded to Equal Weight from Underweight at Morgan Stanley
02/23/22 Citi
Palantir price target lowered to $10 from $13 at Citi
02/18/22 Deutsche Bank
Palantir price target lowered to $15 from $18 at Deutsche Bank
02/17/22 RBC Capital
Palantir price target lowered to $9 from $15 at RBC Capital
NTLA Intellia Therapeutics
$63.52 /

-1.585 (-2.43%)

03/07/22 Brookline
Intellia Therapeutics upgraded to Buy from Hold at Brookline
03/04/22 H.C. Wainwright
Intellia selloff brings buying opportunity, says H.C. Wainwright
03/01/22 Baird
Intellia Therapeutics price target lowered to $83 from $146 at Baird
02/18/22 William Blair
Intellia Therapeutics initiated with an Outperform at William Blair
NTR Nutrien
$98.79 /

+3.75 (+3.95%)

03/07/22 Piper Sandler
Nutrien upgraded to Overweight from Neutral at Piper Sandler
03/04/22 JPMorgan
Nutrien price target raised to $95 from $85 at JPMorgan
02/28/22 Piper Sandler
Nutrien price target raised to $87 from $80 at Piper Sandler
02/22/22 RBC Capital
Nutrien price target raised to $90 from $85 at RBC Capital
DKNG DraftKings
$19.50 /

-1.19 (-5.75%)

03/07/22 Argus
DraftKings cut to Hold at Argus on growing Wynn and MGM competition
03/02/22 Morgan Stanley
Morgan Stanley calls DraftKings top pick in online betting
02/23/22 Citi
DraftKings price target lowered to $35 from $40 at Citi
02/22/22 Needham
DraftKings price target lowered to $32 from $46 at Needham
MGM MGM Resorts
$40.21 /

-1.31 (-3.16%)

02/22/22 Roth Capital
Roth Capital upgrades DraftKings to Neutral, lowers price target to $19
02/10/22 Morgan Stanley
MGM Resorts price target raised to $56 from $52 at Morgan Stanley
02/10/22 Citi
MGM Resorts resumed with a Buy at Citi
WYNN Wynn Resorts
$77.66 /

-3.62 (-4.45%)

02/16/22 CBRE
Wynn Resorts price target raised to $130 from $125 at CBRE
02/16/22 Deutsche Bank
Wynn Resorts price target lowered to $123 from $131 at Deutsche Bank
02/16/22 Wells Fargo
Wynn Resorts price target raised to $99 from $93 at Wells Fargo
AAL American Airlines
$14.07 /

-0.53 (-3.63%)

03/07/22 Seaport Global
American Airlines downgraded to Neutral from Buy at Seaport Global
02/15/22 Wolfe Research
Wolfe upgrades three, downgrades one in U.S. Airlines as new analyst takes over
02/15/22 Wolfe Research
American Airlines assumed at Peer Perform from Underperform at Wolfe Research
01/27/22 Citi
Citi opens positive catalyst watches on American, United
RL Ralph Lauren
$111.24 /

-4.68 (-4.04%)

03/07/22 Wedbush
Ralph Lauren downgraded to Neutral from Outperform at Wedbush
02/15/22 JPMorgan
Ralph Lauren price target raised to $142 from $137 at JPMorgan
02/07/22 UBS
Ralph Lauren price target raised to $171 from $168 at UBS
02/04/22 Truist
Ralph Lauren price target raised to $156 from $141 at Truist
PVH PVH Corp.
$75.11 /

-4.11 (-5.19%)

03/07/22 Wedbush
PVH Corp. downgraded to Neutral from Outperform at Wedbush
02/17/22 BofA
PVH Corp. transferred with a Buy at BofA, price target raised to $156
01/03/22 Guggenheim
Nike remains a 'Best Idea' at Guggenheim heading into 2022
12/15/21 Truist
Truist starts PVH Corp. at Hold given lack of clarity on North American recovery
PM Philip Morris
$95.22 /

-4.52 (-4.53%)

03/07/22 JPMorgan
Philip Morris downgraded to Neutral from Overweight at JPMorgan
02/25/22 Barclays
Philip Morris price target lowered to $120 from $125 at Barclays
02/17/22 UBS
Philip Morris price target raised to $110 from $95 at UBS
01/18/22 Stifel
Stifel says IQOS patent win a 'positive' development for Philip Morris, Altria
SOFI SoFi Technologies
$9.98 /

-0.02 (-0.20%)

03/07/22 Piper Sandler
SoFi Technologies initiated with a Neutral at Piper Sandler
03/02/22 Citi
Citi says buy SoFi after 'solid' Q4, keeps $20 price target
03/02/22 BofA
BofA cuts SoFi Technologies to Neutral on more balanced risk-reward
03/02/22 BofA
SoFi Technologies downgraded to Neutral from Buy at BofA
NVDA Nvidia
$223.94 /

-5.27 (-2.30%)

03/07/22 Goldman Sachs
Nvidia reinstated with a Neutral at Goldman Sachs
02/17/22 Rosenblatt
Nvidia's secular tailwinds 'just beginning,' says Rosenblatt
02/17/22 Mizuho
Nvidia price target raised to $345 from $335 at Mizuho
02/17/22 Summit Insights
Nvidia downgraded to Hold on peaking margins at Summit Insights
PRTG Portage Biotech
$7.59 /

-0.02 (-0.26%)

03/07/22 H.C. Wainwright
Portage Biotech initiated with a Buy at H.C. Wainwright
09/21/21
Fly Intel: Top five analyst initiations
09/21/21 Oppenheimer
Portage Biotech initiated with Outperform, $30 target at Oppenheimer
09/20/21 Oppenheimer
Portage Biotech initiated with an Outperform at Oppenheimer
SGHC Super Group
$7.99 /

-0.16 (-1.96%)

03/07/22 Oppenheimer
Super Group initiated with an Outperform at Oppenheimer
11/30/21 Benchmark
Sports Entertainment Acquisition initiated with a Buy at Benchmark
CCAP Crescent BDC
$17.55 /

+0.025 (+0.14%)

03/07/22 Wells Fargo
Crescent BDC initiated with an Overweight at Wells Fargo
01/31/22 BofA
Crescent BDC initiated with a Buy at BofA
01/31/22 BofA
Crescent BDC initiated with a Buy at BofA
07/16/21 Oppenheimer
Crescent BDC initiated with a Perform, $19 target at Oppenheimer
WYNN Wynn Resorts
$77.66 /

-3.62 (-4.45%)

SOFI SoFi Technologies
$9.98 /

-0.02 (-0.20%)

RL Ralph Lauren
$111.24 /

-4.68 (-4.04%)

PVH PVH Corp.
$75.11 /

-4.11 (-5.19%)

PRTG Portage Biotech
$7.59 /

-0.02 (-0.26%)

PM Philip Morris
$95.22 /

-4.52 (-4.53%)

PLTR Palantir
$11.52 /

+0.57 (+5.21%)

NVDA Nvidia
$223.94 /

-5.27 (-2.30%)

NTR Nutrien
$98.79 /

+3.75 (+3.95%)

NTLA Intellia Therapeutics
$63.52 /

-1.585 (-2.43%)

MGM MGM Resorts
$40.21 /

-1.31 (-3.16%)

FIVE Five Below
$154.00 /

+4.5 (+3.01%)

DKNG DraftKings
$19.50 /

-1.19 (-5.75%)

CRI Carter's
$95.22 /

+1.01 (+1.07%)

AAL American Airlines
$14.07 /

-0.53 (-3.63%)

  • 16
    Nov
  • 16
    Nov
  • 30
    Jun
  • 24
    Jun
WYNN Wynn Resorts
$77.66 /

-3.62 (-4.45%)

RL Ralph Lauren
$111.24 /

-4.68 (-4.04%)

PM Philip Morris
$95.22 /

-4.52 (-4.53%)

PLTR Palantir
$11.52 /

+0.57 (+5.21%)

NVDA Nvidia
$223.94 /

-5.27 (-2.30%)

MGM MGM Resorts
$40.21 /

-1.31 (-3.16%)

DKNG DraftKings
$19.50 /

-1.19 (-5.75%)

AAL American Airlines
$14.07 /

-0.53 (-3.63%)

WYNN Wynn Resorts
$77.66 /

-3.62 (-4.45%)

SOFI SoFi Technologies
$9.98 /

-0.02 (-0.20%)

SGHC Super Group
$7.99 /

-0.16 (-1.96%)

RL Ralph Lauren
$111.24 /

-4.68 (-4.04%)

PVH PVH Corp.
$75.11 /

-4.11 (-5.19%)

PM Philip Morris
$95.22 /

-4.52 (-4.53%)

PLTR Palantir
$11.52 /

+0.57 (+5.21%)

NVDA Nvidia
$223.94 /

-5.27 (-2.30%)

NTR Nutrien
$98.79 /

+3.75 (+3.95%)

NTLA Intellia Therapeutics
$63.52 /

-1.585 (-2.43%)

MGM MGM Resorts
$40.21 /

-1.31 (-3.16%)

FIVE Five Below
$154.00 /

+4.5 (+3.01%)

DKNG DraftKings
$19.50 /

-1.19 (-5.75%)

CRI Carter's
$95.22 /

+1.01 (+1.07%)

AAL American Airlines
$14.07 /

-0.53 (-3.63%)

WYNN Wynn Resorts
$77.66 /

-3.62 (-4.45%)

SOFI SoFi Technologies
$9.98 /

-0.02 (-0.20%)

SGHC Super Group
$7.99 /

-0.16 (-1.96%)

RL Ralph Lauren
$111.24 /

-4.68 (-4.04%)

PVH PVH Corp.
$75.11 /

-4.11 (-5.19%)

PM Philip Morris
$95.22 /

-4.52 (-4.53%)

PLTR Palantir
$11.52 /

+0.57 (+5.21%)

NVDA Nvidia
$223.94 /

-5.27 (-2.30%)

NTR Nutrien
$98.79 /

+3.75 (+3.95%)

MGM MGM Resorts
$40.21 /

-1.31 (-3.16%)

FIVE Five Below
$154.00 /

+4.5 (+3.01%)

DKNG DraftKings
$19.50 /

-1.19 (-5.75%)

CCAP Crescent BDC
$17.55 /

+0.025 (+0.14%)

AAL American Airlines
$14.07 /

-0.53 (-3.63%)

Initiation
Crescent BDC initiated with an Overweight at Wells Fargo » 06:28
03/07/22
03/07
06:28
03/07/22
06:28
CCAP

Crescent BDC

$17.53 /

-0.125 (-0.71%)

Wells Fargo analyst…

Wells Fargo analyst Finian O'Shea initiated coverage of Crescent BDC with an Overweight rating and $19.50 price target. The analyst sees its 0.17-times discount to NAV being "too harsh" in the context of its credit profile and senior debt orientation, underwriting track record, and conservative leverage profile. That said, Crescent BDC's ability to trade at a premium may be limited given its fee structure, style of capital raising, and today's competitive peer set in the 0.95-1.05-times NAV context for quality unitranche-focused BDCs.

ShowHide Related Items >><<
CCAP Crescent BDC
$17.53 /

-0.125 (-0.71%)

01/31/22 BofA
Crescent BDC initiated with a Buy at BofA
01/31/22 BofA
Crescent BDC initiated with a Buy at BofA
07/16/21 Oppenheimer
Crescent BDC initiated with a Perform, $19 target at Oppenheimer
07/16/21 Oppenheimer
Crescent BDC initiated with a Perform at Oppenheimer
  • 16
    Nov
CCAP Crescent BDC
$17.53 /

-0.125 (-0.71%)

Initiation
Crescent BDC initiated with a Buy at BofA » 06:24
01/31/22
01/31
06:24
01/31/22
06:24
CCAP

Crescent BDC

$17.81 /

-0.115 (-0.64%)

BofA analyst Derek Hewett…

BofA analyst Derek Hewett initiated coverage of Crescent BDC with a Buy rating and $19.50 price target. The company is quickly gaining share in the middle market and looks well positioned to capitalize on the supply-demand imbalance as traditional capital providers de-emphasize the unrated middle market space, the analyst tells investors in a research note. Hewett adds that at 0.84-times its net asset value, Crescent Capital BDC presents an "attractive entry point".

ShowHide Related Items >><<
CCAP Crescent BDC
$17.81 /

-0.115 (-0.64%)

01/31/22 BofA
Crescent BDC initiated with a Buy at BofA
07/16/21 Oppenheimer
Crescent BDC initiated with a Perform, $19 target at Oppenheimer
07/16/21 Oppenheimer
Crescent BDC initiated with a Perform at Oppenheimer
  • 16
    Nov
CCAP Crescent BDC
$17.81 /

-0.115 (-0.64%)

Initiation
Crescent BDC initiated with a Buy at BofA » 06:11
01/31/22
01/31
06:11
01/31/22
06:11
CCAP

Crescent BDC

$17.81 /

-0.115 (-0.64%)

BofA analyst Derek Hewett…

BofA analyst Derek Hewett initiated coverage of Crescent BDC with a Buy rating and $19.50 price target.

ShowHide Related Items >><<
CCAP Crescent BDC
$17.81 /

-0.115 (-0.64%)

07/16/21 Oppenheimer
Crescent BDC initiated with a Perform, $19 target at Oppenheimer
07/16/21 Oppenheimer
Crescent BDC initiated with a Perform at Oppenheimer
  • 16
    Nov
CCAP Crescent BDC
$17.81 /

-0.115 (-0.64%)

Options
Four new option listings and three option delistings on December 8th » 08:30
12/08/21
12/08
08:30
12/08/21
08:30
CCAP

Crescent BDC

$18.60 /

+0.03 (+0.16%)

, PL

Planet Labs

$10.81 /

+0.97 (+9.86%)

, DMYQ

dMY Technology Group IV

/

+

, GIG

GigCapital4

$10.02 /

+0.06 (+0.60%)

, MCF

Contango Oil & Gas

$3.21 /

+0.1 (+3.22%)

New option listings for…

New option listings for December 8th include BBAI Stock (BBAI), Crescent Capital (CCAP), PL Stock (PL), and CRGY Stock (CRGY). Option delistings effective December 8th include dMY Technology Group Inc IV (Class A Stock) (DMYQ), GigCapital4 (GIG), and Contango Oil & Gas (MCF).

ShowHide Related Items >><<
PL Planet Labs
$10.81 /

+0.97 (+9.86%)

MCF Contango Oil & Gas
$3.21 /

+0.1 (+3.22%)

GIG GigCapital4
$10.02 /

+0.06 (+0.60%)

DMYQ dMY Technology Group IV
/

+

CCAP Crescent BDC
$18.60 /

+0.03 (+0.16%)

07/16/21 Oppenheimer
Crescent BDC initiated with a Perform, $19 target at Oppenheimer
07/16/21 Oppenheimer
Crescent BDC initiated with a Perform at Oppenheimer
PL Planet Labs
$10.81 /

+0.97 (+9.86%)

09/27/21 Craig-Hallum
dMY Technology Group IV initiated with a Buy, $15 target at Craig-Hallum
DMYQ dMY Technology Group IV
/

+

11/12/21 WestPark Capital
dMY Technology Group IV initiated with a Buy at WestPark Capital
11/09/21 Northland
dMY Technology Group IV initiated with an Outperform at Northland
11/08/21 Benchmark
dMY Technology Group IV initiated with a Buy at Benchmark
GIG GigCapital4
$10.02 /

+0.06 (+0.60%)

11/08/21 Northland
GigCapital4 initiated with an Outperform at Northland
MCF Contango Oil & Gas
$3.21 /

+0.1 (+3.22%)

07/26/21 Stephens
Contango Oil & Gas downgraded to Equal Weight on deal uncertainty at Stephens
07/26/21 Stephens
Contango Oil & Gas downgraded to Equal Weight from Overweight at Stephens
05/04/21 Stephens
Stephens starts Contango Oil & Gas at Overweight with $5 price target
05/03/21 Stephens
Contango Oil & Gas initiated with an Overweight at Stephens
  • 16
    Nov
DMYQ dMY Technology Group IV
/

+

MCF Contango Oil & Gas
$3.21 /

+0.1 (+3.22%)

GIG GigCapital4
$10.02 /

+0.06 (+0.60%)

DMYQ dMY Technology Group IV
/

+

Syndicate
Crescent BDC 2.5M share Spot Secondary priced at $19.35 » 08:14
11/16/21
11/16
08:14
11/16/21
08:14
CCAP

Crescent BDC

$20.46 /

-0.38 (-1.82%)

The correct price is…

The correct price is $19.35. BofA, Wells Fargo, Morgan Stanley, Keefe Bruyette and RBC Capital acted as joint book running managers for the offering.

ShowHide Related Items >><<
CCAP Crescent BDC
$20.46 /

-0.38 (-1.82%)

07/16/21 Oppenheimer
Crescent BDC initiated with a Perform, $19 target at Oppenheimer
07/16/21 Oppenheimer
Crescent BDC initiated with a Perform at Oppenheimer
  • 16
    Nov
Syndicate
Crescent BDC files to sell 2.5M shares of common stock » 16:04
11/15/21
11/15
16:04
11/15/21
16:04
CCAP

Crescent BDC

$20.48 /

-0.36 (-1.73%)

BofA Securities, Wells…

BofA Securities, Wells Fargo Securities, LLC, Morgan Stanley & Co. LLC, Keefe, Bruyette & Woods, A Stifel Company and RBC Capital Markets, LLC are serving as joint book-running managers for the Offering. Oppenheimer & Co. Inc. and SMBC Nikko Securities America, Inc. are serving as co-managers for the Offering.

ShowHide Related Items >><<
CCAP Crescent BDC
$20.48 /

-0.36 (-1.73%)

07/16/21 Oppenheimer
Crescent BDC initiated with a Perform, $19 target at Oppenheimer
07/16/21 Oppenheimer
Crescent BDC initiated with a Perform at Oppenheimer

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.